Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Market Cap	153.08M +4.1%
Revenue (ttm)	227.46M +8.6%
Net Income	14.28M +15.1%
EPS	0.05 +23.8%
Shares Out	221.86M
PE Ratio	13.56
Forward PE	n/a
Dividend	0.03 (3.62%)
Ex-Dividend Date	Jun 25, 2026

Volume	300
Open	0.6900
Previous Close	n/a
Day's Range	0.6900 - 0.6900
52-Week Range	0.6050 - 0.7350
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company operates through Animal Health Products and Food Equipment; Food Ingredients; and others segments. It offers diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services, as well as trades in animal health products. Th...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 205
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: RHONEMA

Financial Performance

In 2025, Rhone Ma Holdings Berhad's revenue was 223.68 million, an increase of 5.81% compared to the previous year's 211.41 million. Earnings were 14.16 million, an increase of 15.07%.